Thus, we suppose that aberrant expression of NAF1 will impact the translation of key molecules in malignant progression of gliomas such as c-Myc, NRF2, and TERT, which have been demonstrated to regulated NAF1 transcription as mentioned above. This evidence concerns the gene NAF1 and central nervous system cancer.